Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tejaswini M. Dhawale"'
Autor:
Tejaswini M. Dhawale, P. Connor Johnson, Mahmoud R. Gaballa, Ashley M. Nelson, Mitchell W. Lavoie, Kofi Y. Boateng, Claire Greydanus, Matthew J. Frigault, Areej El‐Jawahri
Publikováno v:
Cancer. 129:441-449
Chimeric antigen receptor (CAR) T-cell is potentially curative therapy for patients with hematologic malignancies but can cause life-threatening toxicities. Data on perceptions of prognosis and psychological distress are lacking.The authors conducted
Autor:
Hermioni L. Amonoo, Elizabeth Daskalakis, Emma C. Deary, Monica H. Bodd, Matthew J. Reynolds, Ashley M. Nelson, Richard Newcomb, Tejaswini M. Dhawale, Daniel Yang, Selina M. Luger, Jillian L. Gustin, Andrew Brunner, Amir T. Fathi, Thomas W. LeBlanc, Areej El-Jawahri
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1116-1123
Background: Patients with acute myeloid leukemia (AML) face an abrupt life-threatening illness and experience immense physical and psychological symptoms. However, no data describe how patients with AML cope longitudinally with their illness or the r
Autor:
P. Connor Connor Johnson, Tejaswini M. Dhawale, Richard A. Newcomb, Hermioni L. Amonoo, Mitchell W. Lavoie, Dagny M. Vaughn, Kyle Karpinski, Areej El-Jawahri
Publikováno v:
Blood Advances.
CAR-T cell therapy has transformed treatment for relapsed/refractory hematologic malignancies but has complex logistics and unique toxicities. Data examining the patient-reported outcomes (PROs) of CAR-T recipients are limited. We conducted a longitu
Publikováno v:
Hematology/oncology clinics of North America. 31(2)
Peripheral T-cell lymphoma and natural killer/T-cell lymphomas (PT/NKCL) make up a diverse subgroup of non-Hodgkin's lymphomas characterized by an aggressive clinical course. The use of hematopoietic stem cell transplantation (HSCT) in the treatment